Tango Therapeutics, Inc.: cashflow_investing
| Value | {"amount": 13987000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | current |
| Entity | Tango Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:17:35.703091+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/963224fa-9cae-46ad-a707-e45d0f295766
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-22-016257 · Open the official SEC filing →Retrieved: 2026-08-19T18:17:35.703091+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819133/cashflow-investing/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/963224fa-9cae-46ad-a707-e45d0f295766
History
- supersedes {"amount": 32513, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0001213900-21-040828)